Vice-President of Research and Development

Steven Dominguez, Jr

Steven is an International Public Health Policy expert and Biochemist with extensive USA and International research experience. Steven is responsible for our biotechnology R&D. Steven has managed the following corporate biotechnology projects: epidermal and fibroblast growth factor, adipose stem cells, liposome, nanoparticles, and LipoMiracle tumescent fluid.

Steven is the primary author of several peer reviewed journal articles.  

While at the University of Iowa, Steven' focus of research included:

• Synthesis of mesoporous silica nanoparticles for use in development of a drug delivery system.
• Use of Nicotinamide Riboside analogs as precursors in the synthesis of NAD.

Through the National Institiute of Health, MHIRT Program at the Cluj School of Public Health, Babeş-Bolyai University, Cluj-Napoca, Romania, Steven conducted research on: Use of Discrete Choice Experiments to identify factors which influence health professionals’ choice of workplace.  Steven has provided services to multiple international NGO's and is currently assisting FEMA with COVID 19 logistics.